Activating mutation in <it>MET </it>oncogene in familial colorectal cancer
<p>Abstract</p> <p>Background</p> <p>In developed countries, the lifetime risk of developing colorectal cancer (CRC) is 5%, and it is the second leading cause of death from cancer. The presence of family history is a well established risk factor with 25-35% of CRCs attributable to inherited and/or f...
שמור ב:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2011-10-01
|
| סדרה: | BMC Cancer |
| גישה מקוונת: | http://www.biomedcentral.com/1471-2407/11/424 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
